











Validation of the Polish version of the Neurological Disorders Depression 
Inventory for Epilepsy (P-NDDI-E)
Bartłomiej Gmaj 1, Jerzy Majkowski 2, Jan Szczypiński 6,1 Joanna Jędrzejczak 2,3,  
Beata Majkowska-Zwolińska2,8, Marcin Wojnar1, Jacek Gawłowicz 4, Piotr Januszko 1, Sung Pa Park 5,  
Ewa Nagańska3, Simon Ziemka 7, Dorota Wołyńczyk-Gmaj 1
1 Department of Psychiatry, Medical University of Warsaw, Poland
2 Epilepsy Diagnostic and Therapeutic Center, Foundation of  
 Epileptology, Warsaw, Poland
3 Department of Neurology and Epileptology, Medical Center for  
 Postgraduate Education, Warsaw, Poland
4 Department of Neurology, District Specialized Hospital, Lublin,  
 Poland
5 Kyungpook National Hospital, Department of Neurology, School  
 of Medicine Kyungpook National, University, Daegu, South Korea
6 Laboratory of Brain Imaging, Nencki Institute of Experimental  
 Biology, Warsaw, Poland
7 Medical University of Warsaw, Poland
8 Faculty of Medicine, Lazarski University, Warsaw, Poland
Correspondence
Bartłomiej Gmaj, MD, PhD
Department of Psychiatry, Medical University of Warsaw
27 Nowowiejska Str., 00-665 Warsaw, Poland
e-mail: bartekgmaj@gmail.com
phone: +48 22 825 12 36
SUMMARY
Introduction. Depressive symptoms are very frequent in the population of patients with epilepsy. Comor-
bidity between depression and epilepsy is estimated in the range of 9–62%. There are no epidemiological 
studies in Poland thus far in that area and there is no translated and validated screening tool for depres-
sion dedicated for persons with epilepsy (PWEs). In this study we intended to validate the Polish version of 
the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), which is a short and accurate scale 
used in many countries for assessment of depressive symptoms in PWEs.
Aim. The purpose of the study was to validate the Polish version of NDDI-E scale in the sample of PWEs.
Material and methods. The consecutive 257 patients with epilepsy (PWEs) who met inclusion and exclusion 
criteria, were recruited by neurologists-epileptologists during their routine outpatient visits in the period 
from November 2016 to February 2017. The respondents completed the Polish translated version of NDDI-E 
scale and were assessed with the MINI-International Neuropsychiatric Interview (MINI, depression module).
Results. After excluding assessments with missing data, we analyzed data of 253 subjects. Sixty-four pa-
tients (25.1%) had current major depressive disorder (MDD) according to the MINI criteria. The Cronbach’s 
coefficient for the NDDI-E was 0.822. Receiver operating characteristic analyses showed an area under the 
curve of 0.882 (p < 0.001; asymptotic 95% confidence intervals ranged from 0.832 to 0.932). The cut-off 
point of 9 corresponded to sensitivity of 0.766 and specificity of 0.858.
Conclusion. The Polish version of NDDI-E scale after validation with a cut-off 9 points may be a useful tool 
for diagnosing depression in a Polish population of PWEs.
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INTRODUCTION
Patients with epilepsy (PWEs) have worse quality of 
life than individuals from the general population not 
only because of occurrence of epileptic seizures, but 
also due to comorbid psychiatric disorders, especial-
ly depression (Jacoby et al., 2009; Kanner et al., 2012a; 
Yue et al., 2011). These symptoms are severe and more 
frequent in population of patients with epilepsy than 
in the general population (Jalava and Sillanpää, 1996; 
Kwon and Park, 2014; Tellez-Zenteno et al., 2007). Un-
fortunately, occurrence of depression is underestimat-
ed by clinicians treating patients with epilepsy. Ap-
propriate identification of predictors of poor quali-
ty of life is essential for planning long-term therapeu-
tic strategies for such patients (Kwan et al., 2009; Kerr, 
2012; Taylor et al., 2011). The prevalence of depression 
in PWEs has been estimated at between 9% (Jacoby et 
al., 1996) and 62% (Lee et al., 2010). The literature re-
mains inconclusive regarding risk factors of depressive 
disorders in epilepsy.
The NDDI-E is a self-report questionnaire designed 
to screen for a major depressive episode in patients with 
epilepsy (Gilliam et al., 2006). It consists of six state-
ments about the last two weeks that are rated from 
1 (never) to 4 (always/often). The statements were cho-
sen in a way not to overlap with the common epilepsy 
deficits or the side effects of antiepileptic drugs. Each 
inventory item is rated by a PWE on a scale from 1 (nev-
er) to 4 (always or often). The minimum score is 6 and 
the maximum is 24 points. In the original version, the 
score above 15 points has a high predictive value for 
major depression (Gilliam et al., 2006). The NDDI-E 
has been translated from English into other languages 
and approved as a tool for the diagnosis of depression 
in PWEs in Argentina (Thomson et al., 2014), Brazil 
(De Oliveira et al., 2010), Italy (Mula et al., 2012), Chi-
na (Guo et al., 2015), France (Micoulaud-Franchi et al., 
2015), Spain (Di Capua et al., 2012), Korea (Ko et al., 
2012), Japan (Tadokoro et al., 2012), Germany (Met-
ternich et al., 2012) and Greece (Zis et al., 2013). The 
aim of this study was to validate the Polish version of 
the NDDI-E scale.
MATERIAL AND METHODS
The consecutive 257 persons with epilepsy (PWEs), who 
fulfilled inclusion and exclusion criteria, were recruit-
ed by physicians with specialization of neurology and 
epileptology in the period from Nov. 10, 2016 to Feb. 
28, 2017 during their routine outpatient visits. The fol-
lowing epilepsy treatment centers were involved in the 
study: 1. Epilepsy Diagnostic and Therapeutic Center, 
Foundation of Epileptology, Warsaw; 2. Country Hos-
pital, Department of Neurology, Epileptic Clinic, Lu-
blin; 3. Department of Neurology and Epileptology, 
Medical Center for Postgraduate Education, Warsaw. 
All physicians were certified neurologists with certi-
fication of Polish Society of Epileptology as qualified 
epileptologists.
The inclusion criteria were: 1. Consecutive adult pa-
tients (18 years or older), male and female with estab-
lished diagnosis of epilepsy according to the ILAE Clas-
sification of Seizures and Epileptic Syndromes (Com-
mission on Classification and Terminology, 1981, 1985). 
2. The patients have been in the care of the neurologists/
epileptologists. 3. All patients were receiving antiepilep-
tic (AED) medications, which have not been changed 
during last year. 4. The patients who had the ability to 
provide informed consent and who agreed to partici-
pate in the study.
The exclusion criteria were: 1. Possible coexisting 
non-epileptic events, in particular, psychogenic pseu-
doepileptic seizure. 2. Coexisting serious renal, liver or 
blood disorders. 3. Progressive brain disorders, e.g., tu-
mor, degenerative or inflammatory processes. 4. Other 
than depression psychiatric disorders.
After signing the informed consent, the respond-
ents received a questionnaire containing the NDDI-E, 
Polish version, and the questions included in the Ma-
jor Depression Module of the MINI-International Neu-
ropsychiatric Interview (MINI). The attending neu-
rologist interviewed the study participant and com-
pleted the questionnaire containing demographic and 
medical data.
The translation was conducted in accordance with 
the procedure recommended by the authors of the 
original NDDI-E instrument. The English version was 
translated into Polish language by a team of psychia-
trists who fluently speak English and then back-trans-
lated into English by two independent native speakers. 
This version was submitted to the commission of au-
thors of the original version in order to assess whether 
the original meaning of statements was preserved. Af-
ter discussion about the divergences between the orig-
inal English version and back-translated Polish version 
and introduction of recommended modifications, Pol-
ish version was printed and used for this study. As a ref-
erence for NDDI-E we used a validated Polish version 
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of MINI (Masiak and Przychodzka-Masiak, 2002) MI-
NI is a short structured clinical interview, which ena-
bles researchers to make diagnoses of psychiatric dis-
orders. We used only the Major Depression Module 
that is a qualitative test to obtain diagnosis of depres-
sion, which was used to divide the whole study sam-
ple for two subgroups – major depressive episode and 
non-major depressive episode.
Statistical analysis
Reliability analysis was performed using Cronbach’s α 
along with inter-item and corrected item-total corre-
lations (correlation between particular item and total 
score of all other items) for both groups.
The Confirmatory Factor Analysis (CFA) was per-
formed to check whether factor structure of Polish val-
idation of NDDI-E resembles one factor structure of 
the original questionnaire. The data were not normally 
distributed and therefore the Robust Maximum Likeli-
hood method was chosen for the CFA (Li, 2016; Rhem-
tulla et al., 2012). Model fit for each model was evalu-
ated based on χ2, Comparative Fit Index (CFI), Tucker-
Lewis Index (TLI), Standardized Root Means Square 
Residual (SRMR) and Root Means Square Error of Ap-
proximation (RMSEA). Satorra-Bentler correction for 
χ2 was used regardless non-normality of the data.
 The Receiver-Operating Characteristic (ROC) was 
performed to obtain specificity, sensitivity and cut-off 
point. The ROC analysis was obtained by comparing 
the NDDI-E scores between those with and without 
depression based on the MINI items. Between group 
differences in NDDI-E score were also examined and 
were used as indication of validity of NDDI-E. Con-
sidering the non-normal distribution of the NNDI-E 
score in each group the Mann-Whitney U test was per-
formed. Effect size was estimated as r value, which can 
be interpreted as variance explained or variance shared 
between two variables. To check possible influence of 
age and sex on between group differences in NDDI-E 
score additional analysis was performed. Differences in 
age groups between DP and NDP were examined with 
Mann-Whitney U test and differences in proportion 
of men and women between DP and NDP were exam-
ined with χ2 test.
The statistical analysis was performed using the SPSS 
and R software.
Local Ethical Committee
The protocol of the study was submitted and approved 




Two hundred fifty-seven patients participated in this 
study. Four patients were excluded from further ana-
lyses due to missing data. The remaining study popu-
lation consisted of 253 patients of which 104 were men 
and 149 were women (demographic data are present-
ed in Table 1). Mean NDDI-E score was 6.93 (SD = 3.71). 
The total sample was then split into two subgroups 
based on diagnosis of depression using the MINI Ma-
jor Depression Module. This resulted in two groups: 
depressed patients (DP) consisting of 64 individu-
als, with median NDDI-E score of 10 (IQR = 4.25) and 
non-depressed patients (NDP), including 189 indivi-
duals, with median NDDI-E score of 6 (Interquartile 
range (IQR) = 4).
Validation of Polish version inventory – depression in epilepsy
Table 1. Demographic information about participants in 
the study
Number of participants 253
% Female 58.9
% Male 41.1
% Diagnosed with depression 25.3
NDDI-E Age groups (%):




> 65 years 4.3
Years of treatment (SD) 16.8 (12)
Number of seizures (SD) 1.8 (1.6)
Reliability analysis
The reliability analysis resulted in Cronbach’s α = 0.822, 
indicating good internal consistency. The correct-
ed item-total correlations ranged from 0.495 to 0.684, 
showing that most of the items had corrected item-to-
tal correlations values above 0.5. The corrected item-
total correlations and inter-item correlations are pre-
sented in Table 2.
Confirmatory Factor Analysis
Minimum ratio of sample size to number of items was 
fulfilled, which allowed to estimate adequate Confirm-
atory Factor Analysis (CFA) loadings (Everitt, 1975). Fit 
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indices of the NDDI-E model indicated acceptable mod-
el fit. The χ2 test for the NDDI-E reached significance 
(p = 0.027) indicating discrepancy from the real covar-
iance structure of the general population data. How-
ever, other fit indices showed good values: CFI = 0.977, 
TLI = 0.962, RMSEA = 0.069 and SRMR = 0.038. Factor 
loadings of 2-factor model were all significant and were 
ranging from 0.544 to 0.777 (see Table 2).
Validity analysis – Receiver Operating 
Characteristics
The ROC analysis resulted in AUC of 0.882 (p < 0.001; 
asymptotic 95% confidence intervals ranged from 0.832 
to 0.932). The cutoff of 9 points corresponded to sensi-
tivity of 0.766 and specificity of 0.858 (Figure 1).
Between Group differences
Gender differences
There were no differences in number of men and wom-
en between DP and NDP (χ2 = 0.681, p = 0.409).
Age differences
There were no differences in age between DP and NDP; 
Mann-Whitney test was nonsignificant (U = 6400, 
p = 0.449; r = 0.048).
NNDI-E differences
There were significant differences in NDDI-E scores 
between DP and NDP: Mann-Whitney test was signif-
icant (U = 1429, p < 0.001) resulting in r = 0.576, which 
corresponds to the large effect size.
DISCUSSION
The comorbidity of depression and epilepsy is a quite 
common phenomenon; the prevalence of depression 
in epilepsy ranges between 9% and 62%% (Jacoby et 
al., 1996; Lee et al., 2010). Depression has been found 
to commonly occur in temporal lobe epilepsy and has 
been shown to influence quality of life and cognitive 
functioning in these individuals (Jones et al., 2005; 
Kwan et al., 2009; Kerr, 2012; Perrine et al., 1995; Tay-
lor et al., 2011). Generally the relationships between 
the two disorders are not well explained and this im-
portant topic is constantly being explored. In addition, 
scarce data is available on treatment of depression in 
people with epilepsy (Kanner et al., 2012b; Kwon and 
Park, 2014)
There are only few studies analyzing incidence or 
predisposing factors of depression in patients with ep-
ilepsy in Poland (Wiglusz et al., 2017). Scarcity of such 
knowledge may affect strategies of long-term therapy 
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ITEM




1 1.000           0.495 0.544
2 0.469 1.000         0.595 0.650
3 0.411 0.518 1.000       0.684 0.777
4 0.252 0.381 0.491 1.000     0.530 0.603
5 0.354 0.382 0.518 0.464 1.000   0.609 0.685
6 0.387 0.456 0.558 0.412 0.539 1.000 0.643 0.724
Table 2. Inter-item, corrected item-total correlations and factor loadings of NDDI-E (N = 253)
Figure 1. Receiver Operating Characteristics (ROC) of 
NDDI-E score predicting depression diagnosis based on 
The Mini–Mental State Examination (MMSE). The Y axis 
represents Sensitivity (True positive rate), the X axis 
represents 1 – Specificity (False positive rate). The green 
line represents area under the curve (UAC) of 0.5, which 
account for random test accuracy. The blue curve 
represents AUC of NDDI-E score predicting depression 
diagnosis.
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and, as a result, quality of life of patients with epilepsy 
(Zhao et al., 2011). We assumed that this may be large-
ly caused by a lack of standardized tools suitable for 
evaluating depressive symptoms in individuals with 
epilepsy. In many countries NDDI-E scale is used for 
such purposes – this instrument is a short, simple and 
accurate scale that was constructed so that symptoms 
of depression would not overlap with symptoms of epi-
lepsy or side effects of antiepileptic drugs (Thomson et 
al., 2014; De Oliveira et al., 2010; Mula et al., 2012; Guo 
et al., 2015; Micoulaud-Franchi et al., 2015; Di Capua 
et al., 2012; Ko et al., 2012; Tadokoro et al., 2012; Met-
ternich et al., 2012; Zis et al., 2013).
 Presented study aimed at evaluating validity of the 
NDDI-E scale in a Polish sample of persons with epi-
lepsy recruited by neurologist-epileptologists from the 
certified epilepsy centers. We analyzed 255 question-
naires including NDDI-E and MINI-Depression Mod-
ule filled in by PWE. From this group, 25% of patients 
had major depressive disorder (MDD) according to 
the ICD-10 criteria. The Polish version of the NDDI-E 
scale showed excellent reliability and the selected cut-
off of 9 points corresponded to satisfying sensitivity 
and specificity of its diagnostic properties. The above 
analysis allowed us to prove validity of the instrument. 
The NDDI-E scale may be then successfully used in the 
Polish population of people with epilepsy.
 The NDDI-E scale may be useful in every day clini-
cal practice and for further research to explore factors 
having impact on symptoms of depression in epilep-
sy. For example, it would be important to study influ-
ence of particular types of epilepsy on appearance and 
course of depression. It is fully justified to introduce 
the validated NDDI-E scale to the research methodol-
ogy and clinical practice of physicians treating patients 
with epilepsy in Poland.
CONCLUSIONS
In this study we provided the evidence supporting the 
validity of the NDDI-E scale with a cut-off of 9 points 
for Polish population of patients with epilepsy. We con-
firmed that NDDI-E is a suitable tool and we encourage 
to use it in further studies and clinical practice.
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